• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用人胰岛素(重组DNA)成功治疗免疫介导的胰岛素抵抗。

Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA).

作者信息

Maneschi F, Fineberg S E, Kohner E M

出版信息

Diabetes Care. 1982 Nov-Dec;5 Suppl 2:175-9. doi: 10.2337/diacare.5.2.s175.

DOI:10.2337/diacare.5.2.s175
PMID:6765532
Abstract

An 82-yr-old woman with type II diabetes developed antibody-mediated insulin resistance while on mixed pork-beef insulin concomitantly with a non-Hodgkin lymphoma. Insulin resistance was initially treated with highly purified pork insulin, but this was unsuccessful. Treatment with human insulin (recombinant DNA) was associated with marked decrease of both insulin requirement and high-affinity antibodies, increase of free insulin levels, and improvement of diabetic control. This patient's case shows that human insulin can be considered as an alternative treatment for immune-mediated insulin resistance.

摘要

一名82岁的II型糖尿病女性在使用混合猪肉-牛肉胰岛素的同时患有非霍奇金淋巴瘤,出现了抗体介导的胰岛素抵抗。胰岛素抵抗最初用高纯度猪胰岛素治疗,但未成功。使用人胰岛素(重组DNA)治疗与胰岛素需求量和高亲和力抗体显著降低、游离胰岛素水平升高以及糖尿病控制改善有关。该患者的病例表明,人胰岛素可被视为免疫介导的胰岛素抵抗的替代治疗方法。

相似文献

1
Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA).用人胰岛素(重组DNA)成功治疗免疫介导的胰岛素抵抗。
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:175-9. doi: 10.2337/diacare.5.2.s175.
2
Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes.人胰岛素(重组DNA)的受体结合研究及临床效果:对新诊断的I型糖尿病、II型糖尿病、胰岛素抵抗(A型和B型)、胰岛素抗体、胰岛素过敏及“脆性”糖尿病患者的研究
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:152-60. doi: 10.2337/diacare.5.2.s152.
3
Resistance and allergy to recombinant human insulin.对重组人胰岛素的耐药性和过敏反应。
J Allergy Clin Immunol. 1990 Jul;86(1):45-51. doi: 10.1016/s0091-6749(05)80122-8.
4
[Comparison of human monocomponent insulin with beef and pork monocomponent insulin in the treatment of a diabetic with insulin resistance].[人单组分胰岛素与牛和猪单组分胰岛素治疗胰岛素抵抗糖尿病患者的比较]
Zhonghua Nei Ke Za Zhi. 1987 Nov;26(11):644-5, 677.
5
Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.胰岛素治疗的糖尿病患者中,无论有无胰岛素抵抗,IgG胰岛素抗体对人(重组DNA)胰岛素和猪胰岛素的亲和力。
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:114-8. doi: 10.2337/diacare.5.2.s114.
6
Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.高滴度胰岛素抗体糖尿病患者中高纯度猪胰岛素和人胰岛素的免疫原性
Taiwan Yi Xue Hui Za Zhi. 1989 Apr;88(4):346-51.
7
Immunological insulin resistance due to insulin antibodies developed after cessation of insulin therapy in a patient with type 2 diabetes.一名2型糖尿病患者在胰岛素治疗停止后因产生胰岛素抗体而出现免疫性胰岛素抵抗。
Diabetes Care. 2008 Nov;31(11):e84. doi: 10.2337/dc08-1431.
8
Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin.
Diabetes Care. 1992 May;15(5):702-4. doi: 10.2337/diacare.15.5.702.
9
Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
Diabetes Care. 1988 Jan;11(1):59-62. doi: 10.2337/diacare.11.1.59.
10
Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.在先用猪胰岛素或牛胰岛素预处理的糖尿病患者中使用人胰岛素(重组DNA)治疗:一项多中心研究的初步结果。
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:140-8. doi: 10.2337/diacare.5.2.s140.

引用本文的文献

1
Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump.外源性胰岛素抗体综合征(EIAS)在一名老年1型糖尿病长期患者中出现,该患者通过霉酚酸酯和胰岛素泵进行低成本门诊治疗后病情得到缓解。
Diabetes Ther. 2024 Jun;15(6):1473-1481. doi: 10.1007/s13300-024-01573-y. Epub 2024 Apr 24.
2
Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetes.胰岛素治疗糖尿病患者中抗胰岛素抗体介导的血糖波动的诊断与治疗。
Diabet Med. 2023 Nov;40(11):e15194. doi: 10.1111/dme.15194. Epub 2023 Sep 1.
3
Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy.
新诊断1型糖尿病患者经口服免疫抑制单药治疗成功后发生外源性胰岛素抗体综合征
Diabetes Ther. 2021 Oct;12(10):2795-2799. doi: 10.1007/s13300-021-01129-4. Epub 2021 Aug 17.
4
Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.外源性胰岛素抗体综合征(EIAS):一种与糖尿病患者外源性胰岛素诱导产生的胰岛素抗体相关的临床综合征。
Endocr Connect. 2018 Jan;7(1):R47-R55. doi: 10.1530/EC-17-0309. Epub 2017 Dec 12.
5
Choice of insulin.胰岛素的选择。
Br Med J (Clin Res Ed). 1983 Nov 26;287(6405):1571-2. doi: 10.1136/bmj.287.6405.1571.
6
Immunogenicity of recombinant DNA human insulin.
Diabetologia. 1983 Dec;25(6):465-9. doi: 10.1007/BF00284452.
7
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.
Drugs. 1987 Sep;34(3):350-71. doi: 10.2165/00003495-198734030-00003.
8
Human insulin.人胰岛素
Br Med J (Clin Res Ed). 1986 Jan 18;292(6514):155-7. doi: 10.1136/bmj.292.6514.155.